Seladelpar Could 'Raise the Bar' in PBC Treatment
The investigational agent significantly improved liver biomarkers of disease activity and symptoms of pruritus in adults with PBC enrolled in a phase 3 trial.
Source: medscape.com
Stay updated with breaking news from Davidn Assis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The investigational agent significantly improved liver biomarkers of disease activity and symptoms of pruritus in adults with PBC enrolled in a phase 3 trial.
Yale’s Digestive Diseases Faculty Acknowledged For Expertise